Serum Chemerin Levels in relation to Osteoporosis and Bone Mineral Density: A Case-Control Study
Table 1
Characteristics of the subjects.
Osteoporosis
Control
P value
Number
93
93
Male/female
34/59
34/59
Age
64.60 ± 10.29
64.48 ± 10.29
0.443
BMI
26.06 ± 2.74
25.24 ± 2.10
<0.01
Number of patients with DM
34
28
0.437
Number of patients with hypertension
38
35
0.764
Number of postmenopausal women
55
50
0.239
Number of patients with bone fracture
15
0
<0.01
Chemerin (ng/ml)
87.27 ± 5.80
71.13 ±5.12
<0.01
FBMD (g/cm2)
0.63 ± 0.04
0.80 ± 0.07
<0.01
LBMD (g/cm2)
0.78 ± 0.04
1.04 ± 0.10
<0.01
TC (mmol/L)
6.35 ± 0.48
6.23 ± 0.45
0.077
TG (mmol/L)
1.69 ± 0.23
1.60 ± 0.36
0.067
HDL-C (mmol/L)
1.47 ± 0.29
1.50 ± 0.35
0.356
LDL-C (mmol/L)
3.00 ± 0.24
3.12 ± 0.24
<0.01
AKP (U/L)
99.29 ± 21.31
92.99 ± 21.03
0.047
FBG (mmol/L)
6.04 ± 1.20
5.81 ± 1.13
0.136
Insulin (mU/L)
17.13 ± 4.52
18.12 ± 3.82
0.079
Data are presented as mean (standard deviation). BMI: body mass index; DM: diabetes mellitus; FBMD: femoral bone mineral density; LBMD: lumbar bone mineral density; TC: total cholesterol; TG: triglycerides; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; AKP: alkaline phosphatase; FBG: fasting blood glucose.
